| Literature DB >> 30873024 |
Rohit Kumar Verma1,2, Thomas Paraidathathu3, Nur Akmar Taha4, Wei Wen Chong2.
Abstract
In Malaysia, sharp increment in the prevalence of obesity over the last four decades has been documented. Community pharmacists (CPs) are strategically placed to tackle obesity by providing weight managements services (WMS) to general public. This study assessed the attitudes, practices and perceived barriers of Malaysian CPs to the provision of WMS. A cross-sectional, descriptive survey was conducted, and responses related to attitudes, practices and perceived barriers of CPs were collected using five-point Likert scale. A total of 550 pharmacists who worked across six states of Malaysia (Selangor, Federal Territory of Kuala Lumpur, Pulau Pinang, Johor, Sabah, and Melaka) participated in this study. Most of the CPs strongly agreed that over eating (n = 312, 56.7%) and sedentary lifestyles (n = 297, 54.0%) contribute to obesity and overweight. Most of them also strongly agreed that exercise training is an effective weight reduction strategy (n = 285, 51.9%), but they were generally not in favor of surgery (n = 231, 42% disagreed/strongly disagreed). CPs generally perceived barriers related to a lack of staff to provide WMS (n = 308, 56.0% agreed/strongly agreed) and ethical and legal issues associated with sales of products/drugs for obesity management (n = 285, 51.9% agreed/strongly agreed). Sociodemographic and practice characteristics such as age group, type of pharmacy, highest education qualification, and employment status of CPs influenced the attitudes, practices and perceived barriers associated with WMS. In terms of age, CPs who were aged less then 30 years expressed significantly stronger agreement that medication adherence is beneficial for weight loss compared to those CPs between 41-50 years. Additionally, CPs who were pharmacy owners provided significantly more frequent BMI measurement and patient information materials as part of their weight management practices compared to CPs who worked as a part timer/locum. This study could be taken as a baseline study on Malaysian CPs' perceptions on WMS.Entities:
Keywords: Malaysia; attitude; barriers; obesity; pharmacists; practices
Year: 2019 PMID: 30873024 PMCID: PMC6401648 DOI: 10.3389/fphar.2019.00138
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
Sociodemographic and practice characteristics of the respondents.
| Characteristics | |
|---|---|
| Female | 361 (65.6) |
| Male | 189 (34.4) |
| Under 30 | 173 (31.5) |
| 30–40 | 245 (44.5) |
| 41–50 | 83 (15.1) |
| 51–60 | 38 (6.9) |
| 61–70 | 10 (1.8) |
| More than 70 | 1 (0.2) |
| Malay | 89 (16.2) |
| Chinese | 421 (76.5) |
| Indian | 37 (6.7) |
| Others | 3 (0.5) |
| Bachelor’s degree | 473 (86.0) |
| Master’s degree | 76 (13.8) |
| Doctoral degree | 1 (0.2) |
| Independent pharmacy | 342 (62.2) |
| Chain pharmacy | 208 (37.8) |
| Part time employee/locum pharmacist | 94 (17.1) |
| Permanent employee | 286 (52) |
| Pharmacy owner | 159 (28.9) |
| Details not available | 11 (2) |
| Penang | 50 (9.1) |
| Johor | 21 (3.8) |
| Melaka | 21 (3.8) |
| Sabah | 78 (14.2) |
| Federal Territory Kuala Lumpur | 219 (39.8) |
| Selangor | 161 (29.3) |
Community pharmacist’s attitude regarding obesity and overweight.
| In your opinion what are the causes of | SD | D | N | A | SA | Median |
|---|---|---|---|---|---|---|
| obesity and overweight? | (IQR) | |||||
| Over eating | 8 (1.5) | 6 (1.1) | 6 (1.1) | 218 (39.6) | 312 (56.7) | 5 (4-5) |
| Sedentary life style | 9 (1.6) | 2 (0.4) | 10 (1.8) | 232 (42.2) | 297 (54.0) | 5 (4-5) |
| Eating at restaurants | 15 (2.7) | 121 (22.0) | 111 (20.2) | 231 (42.0) | 72 (13.1) | 4 (3-4) |
| High fat diet and repeat diet | 8 (1.5) | 18 (3.3) | 36 (6.5) | 268 (48.7) | 220 (40.0) | 4 (4-5) |
| Genetic factors | 6 (1.1) | 36 (6.5) | 73 (13.3) | 350 (63.6) | 85 (15.5) | 4 (4-4) |
| Hormonal problems | 5 (0.9) | 16 (2.9) | 69 (12.5) | 378 (68.7) | 82 (14.9) | 4 (4-4) |
| Consumption of alcohol | 5 (0.9) | 34 (6.2) | 91 (16.5) | 323 (58.7) | 97 (17.6) | 4 (4-4) |
| Stress, anxiety, depression | 3 (0.5) | 41 (7.5) | 94 (17.1) | 326 (59.3) | 86 (15.6) | 3 (4-4) |
| Psychological problems | 4 (0.7) | 45 (8.2) | 118 (21.5) | 306 (55.6) | 77 (14.0) | 4 (3-4) |
| Family culture/environment | 4 (0.7) | 27 (4.9) | 60 (10.9) | 355 (64.5) | 104 (18.9) | 4 (4-4) |
| I think weight loss surgery is effective. | 55 (10.0) | 176 (32.0) | 133 (24.2) | 162 (29.5) | 24 (4.4) | 3 (2-4) |
| I think dietary supplements are effective. | 8 (1.5) | 66 (12.0) | 107 (19.5) | 329 (59.8) | 40 (7.3) | 4 (3-4) |
| I feel exercise training is effective. | 0 (0.0) | 3 (0.5) | 11 (2.0) | 251 (45.6) | 285 (51.8) | 5 (4-5) |
| In my opinion medications are effective. | 14 (2.5) | 53 (9.6) | 80 (14.5) | 358 (65.1) | 45 (8.2) | 4 (3-4) |
| Counseling by dieticians is effective. | 0 (0.0) | 6 (1.1) | 70 (12.7) | 363 (66.0) | 111 (20.2) | 4 (4-4) |
| Patient medication adherence is beneficial | 1 (0.2) | 17 (3.1) | 65 (11.8) | 346 (62.9) | 121 (22.0) | 4 (4-4) |
| Effective treatment of obesity requires teamwork amongst health professionals. | 0 (0.0) | 12 (2.2) | 21 (3.8) | 288 (52.4) | 229 (41.6) | 4 (4-5) |
| Community pharmacist should be role models to manage overweight and obesity. | 1 (0.2) | 11 (2.0) | 34 (6.2) | 354 (64.4) | 150 (27.3) | 4 (4-5) |
| I feel I am well prepared to manage overweight and obese patients | 3 (0.5) | 37 (6.7) | 146 (26.5) | 298 (54.2) | 66 (12.0) | 4 (3-4) |
| Community pharmacists alone cannot manage obesity and overweight effectively | 17 (3.1) | 78 (14.2) | 60 (10.9) | 318 (57.8) | 77 (14.0) | 4 (3-4) |
| Training programs like “My Weight My Health” (MWMH) will help to improve my confidence. | 4 (0.7) | 11 (2.0) | 79 (14.4) | 330 (60.0) | 126 (22.9) | 4 (4-4) |
Current weight management practices.
| I provide the following WM services in the pharmacy | ||||||
|---|---|---|---|---|---|---|
| A. Anthropometric/physiological | Never | Rarely | Occasionally | Often | Always | Median |
| (IQR) | ||||||
| Measurement of weight | 27 (4.9) | 56 (10.2) | 20 (3.6) | 309 (56.2) | 138 (25.1) | 4 (4-5) |
| Measurement of height | 58 (10.5) | 100 (18.2) | 35 (6.4) | 268 (48.7) | 89 (16.2) | 4 (2-4) |
| Calculation of body mass index (BMI) | 37 (6.7) | 47 (8.5) | 19 (3.5) | 325 (59.1) | 122 (22.2) | 4 (4-4) |
| Measurement of waist/hip circumference | 59 (10.7) | 127 (23.1) | 58 (10.5) | 225 (40.9) | 81 (14.7) | 4 (2-4) |
| Measurement of body fat percentage | 63 (11.5) | 132 (24.0) | 67 (12.2) | 210 (38.2) | 78 (14.2) | 4 (2-4) |
| Measurement of blood pressure | 23 (4.2) | 12 (2.2) | 16 (2.9) | 337 (61.3) | 162 (29.5) | 4 (4-5) |
| Measurement of blood glucose | 27 (4.9) | 11 (2.0) | 18 (3.3) | 330 (60.0) | 164 (29.8) | 4 (4-5) |
| Measurement of blood cholesterol | 42 (7.6) | 43 (7.8) | 30 (5.5) | 312 (56.7) | 123 (22.4) | 4 (4-4) |
| Advice on physical activity to achieve weight loss. | 6 (1.1) | 17 (3.1) | 17 (3.1) | 321 (58.4) | 189 (34.4) | 4 (4-5) |
| Advices on healthy eating to achieve weight loss. | 5 (0.9) | 17 (3.1) | 13 (2.4) | 310 (56.4) | 205 (37.3) | 4 (4-5) |
| Sale of weight loss products other than drugs (e.g., dietary aids, supplements). | 7 (1.3) | 22 (4.0) | 40 (7.3) | 363 (66.0) | 118 (21.5) | 4 (4-4) |
| Sale of weight loss drugs. | 29 (5.3) | 77 (14.0) | 65 (11.8) | 305 (55.5) | 74 (13.5) | 4 (3-4) |
| Distribution of patient information materials (e.g., leaflets, popular diet books and video CD’s). | 40 (7.3) | 96 (17.5) | 77 (14.0) | 263 (47.8) | 74 (13.5) | 4 (3-4) |
| Referral to doctors and/or dieticians. | 35 (6.4) | 85 (15.5) | 76 (13.8) | 284 (51.6) | 70 (12.7) | 4 (3-4) |
Barriers to the provision of WMS in community pharmacies.
| Perceived barriers: | SD | D | N | A | SA | Median |
|---|---|---|---|---|---|---|
| (IQR) | ||||||
| Patients are not willing to avail the weight management services in pharmacy. | 13 (2.4) | 144 (26.2) | 127 (23.1) | 230 (41.8) | 36 (6.5) | 3 (2-4) |
| I am very busy to provide WM services in my pharmacy. | 37 (6.7) | 275 (50.0) | 82 (14.9) | 142 (25.8) | 14 (2.5) | 4 (4-4) |
| I would require extra payment to provide weight management services. | 35 (6.4) | 190 (34.5) | 148 (26.9) | 149 (27.1) | 28 (5.1) | 3 (3-4) |
| I am apprehensive regarding ethical and legal issues related to products/drugs used in obesity management. | 13 (2.4) | 106 (19.3) | 146 (26.5) | 250 (45.5) | 35 (6.4) | 2 (2-3) |
| I do not wish to provide weight management services. | 88 (16.0) | 343 (62.4) | 88 (16.0) | 23 (4.2) | 8 (1.5) | 4 (4-4) |
| More staff would be needed to provide weight management services. | 13 (2.4) | 124 (22.5) | 105 (19.1) | 280 (50.9) | 28 (5.1) | 2 (2-3) |
| Providing weight management services in my pharmacy will increase my workload. | 23 (4.2) | 162 (29.5) | 114 (20.7) | 227 (41.3) | 24 (4.4) | 3 (2-4) |
| My pharmacy does not have a private consultation room. | 65 (11.8) | 242 (44.0) | 43 (7.8) | 177 (32.2) | 23 (4.2) | 4 (4-4) |
| My pharmacy doesn’t have relevant machines/equipment to provide weight management services. | 66 (12.0) | 281 (51.1) | 46 (8.4) | 139 (25.3) | 18 (3.3) | 4 (4-4) |
| I believe that providing weight management services is not a part of my responsibilities/duties. | 123 (22.4) | 335 (60.9) | 50 (9.1) | 33 (6.0) | 9 (1.6) | 4 (4-4) |